Shun Asami

Shun Asami currently serves as an Investor at Eisai Innovation, where he focuses on identifying and evaluating strategic venture opportunities within the broader life sciences sector. In this specific capacity, he targets early-stage investments at the intersection of fundamental science and applied healthcare, seeking out novel emerging technologies that align with corporate objectives. His primary investment mandate involves sourcing promising biotechnology startups and digital health platforms capable of generating operational or clinical synergies across the global Eisai network of companies. By leveraging the extensive research and development infrastructure of the parent pharmaceutical organization, Asami actively helps prospective portfolio companies accelerate their clinical pipelines and navigate complex regulatory environments. Ultimately, his current professional focus centers on deploying strategic corporate capital into innovative therapeutic modalities and advanced healthcare solutions that address critical unmet medical needs for patients worldwide.